Biotechnology Stocks I Performance Guide: Catalyst Pharmaceuticals, Inc. (CPRX)
CPRX has no dividends.
Table and Chart of CPRX Performance
See what a $1,000 investment in CPRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CPRX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $2.20 |
| End Date | May-10-2024 |
| End Price | $15.94 |
| # Prices | 121 |
| Min Date | May-31-2016 |
| Min Price | $0.62 |
| Max Date | Dec-30-2022 |
| Max Price | $18.60 |
| Total Return | 624.55% |
| Annualized Return | 21.70% |
| Current Value of $1,000 Purchase | $7,245 |
| Number Returns | 7,260 |
| Average Return | 207.53% |
| Number Profitable Returns | 5,941 |
| Percent Profitable Returns | 81.83% |
| Number Unprofitable Returns | 1,319 |
| Percent Unprofitable Returns | 18.17% |
| Profitable to Unprofitable Returns Ratio | 4.50 |
| CPRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,846,872,000 |
| Beta | 0.880 | Price to Sales | 4.51 |
| Earnings per Share | $0.5600 |
| PE Ratio | 27.95 |
| PE to Growth Ratio | 0 |
| Price to Book | 4.631 |
| PRICE DATA | |
| 52 Week High | $17.5 |
| 52 Week Low | $11.09 |
| Analyst Target Price | $26.71 |
| 50-Day Moving Average | $15.68 |
| 200-Day Moving Average | $14.28 |
| FINANCIAL DATA | |
| Revenue per Share | $3.771 |
| Revenue | $411,347,000 |
| Profit Margin | 15.8% |
| Return on Equity | 14.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CPRX Compare Returns with S&P 500
CPRX Trendline Chart
CPRX Moving Average Chart
CPRX Stock Return Map - See Patterns of Gains and Losses
CPRX Stock Returns/Purchase Dates